Author:
Brennan Julia R.,Sharma Rahul,Lindquist Nathan R.,Cass Nathan D.,Krishnapura Shreyas G.,Kloosterman Nicole,Perkins Elizabeth,Bennett Marc L.,O'Malley Matthew R.,Haynes David S.,Tawfik Kareem O.
Abstract
Objective
We reviewed a cohort of patients with untreated sporadic vestibular schwannoma (VS) and examined the relationship between high-frequency hearing loss (HFHL) in the non-VS ear and long-term hearing outcomes in the VS-affected ear. We hypothesized that the progression of HFHL is associated with accelerated hearing decline in sporadic VS.
Study Design
Retrospective cohort study.
Setting
Tertiary center.
Patients
We studied 102 patients with sporadic VS diagnosed from 1999 to 2015 with ≥5 years of observation (median, 6.92; interquartile range, 5.85–9.29). Sixty-six patients had AAO-HNS class A/B hearing at presentation and were included in analysis.
Interventions
Audiometry, serial magnetic resonance imaging for observation of VS.
Main Outcome Measures
Four-frequency pure tone average (PTA) and word recognition scores (WRS) in the VS-affected ear. Decline in high-frequency PTA (average of thresholds at 4000, 6000, and 8,000 Hz) was defined as ≥10 dB during the study period. Decline in WRS was defined as ≥10%.
Results
Compared with those without, patients with progressive HFHL in the non-VS ear were more likely to experience a decline in WRS in the VS ear (80% vs. 54%, p = 0.031). However, the same group showed no difference (52% vs. 41%, p = 0.40) in decline in PTA of the VS ear.
Conclusions
Patients with observed VS who experience progressive HFHL in the non-VS ear are more likely to experience significant declines in speech understanding in the VS-affected ear over time. Patients with a history of presbycusis may have an increased risk of losing serviceable hearing because of sporadic VS.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Sensory Systems,Otorhinolaryngology